Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis

CP Matthews, AM Birkholz, AR Baker, CM Perella… - Cancer research, 2007 - AACR
Activation of activator protein 1 (AP-1) and nuclear factor κB (NFκB)–dependent transcription
is required for tumor promotion in cell culture models and transgenic mice. Dominant …

A dominant negative mutant of jun blocking 12‐O‐tetradecanoylphorbol‐13‐acetate–induced invasion in mouse keratinocytes

Z Dong, HC Crawford, V Lavrovsky… - … in cooperation with …, 1997 - Wiley Online Library
We previously reported that induced activator protein‐1 (AP‐1) transcriptional activity
appears to be required for tumor promoter–induced transformation in mouse epidermal JB6 …

Induced expression of dominant‐negative c‐jun downregulates NFκB and AP‐1 target genes and suppresses tumor phenotype in human keratinocytes

JJ Li, Y Cao, MR Young… - … : Published in cooperation …, 2000 - Wiley Online Library
Neoplastically transformed mouse and human keratinocytes elevate transactivation of both
activator protein 1 (AP‐1) and nuclear factor κB (NFκB) transcription factors. The present …

Targeting of noncanonical Wnt5a signaling by AP-1 blocker dominant-negative Jun when it inhibits skin carcinogenesis

MIL Kang, AR Baker, CR Dextras… - Genes & …, 2012 - journals.sagepub.com
The transcription factor AP-1 (activator protein-1) regulates a number of genes that drive
tumor promotion and progression. While basal levels of AP-1 activity are important for …

Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion

MR Young, JJ Li, M RINCon… - Proceedings of the …, 1999 - National Acad Sciences
Activator protein-1 (AP-1) is a transcription factor that consists of either a Jun-Jun
homodimer or a Jun-Fos heterodimer. Transactivation of AP-1 is required for tumor promoter …

Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human …

JJ Li, JS Rhim, R Schlegel, KH Vousden, NH Colburn - Oncogene, 1998 - nature.com
AP-1 transactivation appears to be required for mouse JB6 cell neoplastic transformation
induced by the tumor promoter TPA or epidermal growth factor (EGF). Exposure to AP-1 …

Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation

A Dhar, J Hu, R Reeves, L Resar, NH Colburn - Oncogene, 2004 - nature.com
Activation of the transcription factor AP-1 (activator protein-1) is required for tumor promotion
and maintenance of malignant phenotype. A number of AP-1-regulated genes that play a …

A Dominant Negative c-jun Specifically Blocks Okadaic Acid-induced Skin Tumor Promotion

EJ Thompson, J MacGowan, MR Young, N Colburn… - Cancer research, 2002 - AACR
Okadaic acid (OA) is a prototypical non-phorbol ester skin tumor-promoting agent that works
by inhibiting protein phosphatases, leading to an increase in protein phosphorylation …

Protection against human papillomavirus type 16‐E7 oncogene‐induced tumorigenesis by in vivo expression of dominant‐negative c‐jun

MR Young, L Farrell, P Lambert… - … in cooperation with …, 2002 - Wiley Online Library
Expression of the human papillomavirus (HPV) type 16 E6 and E7 gene products is a risk
factor for human cervical carcinogenesis as well as skin and oral carcinogenesis …

Tumour necrosis factor-α mediates tumour promotion via a PKCα-and AP-1-dependent pathway

CH Arnott, KA Scott, RJ Moore, A Hewer, DH Phillips… - Oncogene, 2002 - nature.com
Tumour necrosis factor-α (TNF-α) deficient mice (TNF-α−/− mice) are resistant to skin
carcinogenesis. Cellular signalling via the transcription factor complex AP-1 is thought to …